Overview

DSUVIA Early Evaluation of Pain Trial

Status:
Not yet recruiting

Trial end date:
2025-04-01

Target enrollment:

Participant gender:

Summary

Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain

Phase:

Phase 3

Details

Lead Sponsor:

Frank Guyette

Collaborator:

United States Department of Defense

Treatments:

Sufentanil